ArticleJCO global oncology2020

Effectiveness of Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in a Real-Life Setting: One Decade of Experience Under National Treatment Coverage Regulations.

Natalia Camejo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.